Related Experiment Video
Updated: Mar 6, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
Insights
Vascular Ehlers Danlos syndrome (vEDS) is a rare genetic disorder caused by COL3A1 variants. Early diagnosis and comprehensive management are crucial for preventing life-threatening complications like arterial rupture.
Area of Science:
- Genetics
- Vascular Biology
- Rare Diseases
Background:
- Vascular Ehlers Danlos syndrome (vEDS) is a rare, life-threatening genetic connective tissue disorder.
- It is characterized by arterial aneurysms, dissections, ruptures, bowel, and uterine rupture.
- Pathogenic variants in COL3A1, encoding type III procollagen, are the primary cause.
Purpose of the Study:
- To provide a consensus-based summary of recommendations for the management of vEDS.
- To outline strategies for diagnosis, lifestyle modification, and multidisciplinary care.
- To emphasize the importance of specialized care centers and regular surveillance.
Main Methods:
- Consensus development by an international group of specialists.
- Review of clinical features, genetic basis (COL3A1 variants), and management strategies.
- Formulation of recommendations for diagnosis, lifestyle, team care, emergency planning, and surveillance.
Main Results:
- Diagnosis relies on clinical recognition and genetic identification of COL3A1 variants.
- Management focuses on minimizing injury risk, aggressive blood pressure control, and regular vascular surveillance.
- Multidisciplinary care teams and personalized emergency plans are essential.
Conclusions:
- Established recommendations for vEDS management based on expert consensus.
- Highlights the need for early identification of causative COL3A1 variants.
- Advocates for proactive, specialized care to mitigate severe vascular and organ rupture risks.
Abstract:
Vascular Ehlers Danlos syndrome (vEDS) is an uncommon genetic disorders characterized by arterial aneurysm, dissection and rupture, bowel rupture, and rupture of the gravid uterus. The frequency is estimated as 1/50,000-1/200,000 and results from pathogenic variants in COL3A1, which encodes the chains of type III procollagen, a major protein in vessel walls and hollow organs. Initial diagnosis depends on the recognitions of clinical features, including family history. Management is complex and requires multiple specialists who can respond to and manage the major complications. A summary of recommendations for management include: Identify causative variants in COL3A1 prior to application of diagnosis, modulate life style to minimize injury, risk of vessel/organ rupture, identify and create care team, provide individual plans for emergency care ("vascular EDS passport") with diagnosis and management plan for use when traveling, centralize management at centers of excellence (experience) when feasible, maintain blood pressure in the normal range and treat hypertension aggressively, surveillance of vascular tree by doppler ultrasound, CTA (low radiation alternatives) or MRA if feasible on an annual basis. These recommendations represent a consensus of an international group of specialists with a broad aggregate experience in the care of individuals with vascular EDS that will need to be assessed on a regular basis as new information develops. © 2017 Wiley Periodicals, Inc.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Mitral Valve Prolapse II: Assessment and Management
Rheumatic Heart Disease III: Medical Management

